The late seed round was co-led by Fundracer Capital and EIT Urban Mobility to bring computer vision hardware to market.
"ADAS technology for cars advances daily. We believe that, just like cars, ARAS will be just as commonplace on bikes and motorbikes in the coming years. Six in ten people are still too afraid to cycle in their area. Fear of mixing in traffic is a crucial barrier preventing people from getting on a bike — especially in busy cities. ARAS can help the bike industry capture new segments, particularly commuter cyclists, where the element of fear is highest. In most countries, people will wait years for perfect cycling infrastructure. Meanwhile, technology is already here that can play a huge role in bridging that gap, helping everyone feel safer as they move through their city."
The funding will support service enhancement and customer scaling for the gig economy platform.
"Too many freelance platforms are designed to keep people dependent, distracted, and paying fees just to stay visible. We built Shoutt to flip that dynamic. Our goal is to give freelancers back control over their time, their income, and the work they choose to take on. This funding, which we are delighted to have secured, lets us keep building the infrastructure freelancers actually need to run independent, sustainable businesses on their own terms."
The seed round was led by Flybridge Capital Partners to accelerate the development of developer infrastructure for voice agents.
"Voice AI is having a moment, yet many enterprise projects stall between an impressive demo and a dependable production rollout. This seed round accelerates our work on the. infrastructure that makes enterprise voice systems scalable and durable. We give teams code ownership, deployment flexibility, and deep observability so they can move fast, clear security reviews, and deliver production-ready solutions at scale"
The oversubscribed financing was led by Ahren Innovation Capital and will support preclinical validation and platform development.
"Partnering with the team at o2h discovery is a fantastic milestone for OutSee as we look ahead to commencing our first drug discovery programme and showcasing the potential of our Nomaly platform to revolutionise target discovery. The agreement is testament to the strength of our technology and, in combination with the closure of our oversubscribed seed funding round, kicks off a very exciting year. Thank you to our investors and supporters for their continued support, and the hard work and dedication of our team."
.png)
